11,278
Total Claims
$2.0M
Drug Cost
2,668
Beneficiaries
$755
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-36%
Cost per patient vs peers
$755 vs $1,174 avg
+88%
Brand preference vs peers
16.7% vs 8.9% avg
Brand vs Generic
83% generic
Brand: 1,883 claims · $1.8M
Generic: 9,395 claims · $253K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 911 | $933K |
| Rivaroxaban | 326 | $406K |
| Sacubitril/Valsartan | 203 | $199K |
| Evolocumab | 120 | $91K |
| Empagliflozin | 38 | $40K |
| Alirocumab | 54 | $37K |
| Dofetilide | 87 | $33K |
| Metoprolol Succinate | 1,153 | $29K |
| Ticagrelor | 26 | $21K |
| Atorvastatin Calcium | 1,016 | $18K |
| Rosuvastatin Calcium | 423 | $16K |
| Propafenone Hcl | 22 | $15K |
| Dabigatran Etexilate Mesylate | 15 | $10K |
| Flecainide Acetate | 170 | $10K |
| Diltiazem Hcl | 208 | $9,652 |
Prescribing Profile
52
Unique Drugs
$1.6M
Patient Profile
76
Avg Age
48%
Female
1.34
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data